1193388-07-6 Usage
Description
t-Butyl (2-aMinocyclopentyl)carbaMate, also known as tert-Butyl (2-aminocyclopentyl)carbamate, is a chemical compound with the CAS number 1193388-07-6. It is characterized by its unique molecular structure, which consists of a tert-butyl group attached to a carbamate functional group, with a 2-aminocyclopentyl moiety as a substituent. tert-Butyl (2-aMinocyclopentyl)carbaMate is known for its potential applications in the pharmaceutical and chemical industries due to its specific reactivity and structural features.
Uses
Used in Pharmaceutical Industry:
t-Butyl (2-aMinocyclopentyl)carbaMate is used as a reactant in the synthetic preparation of carboxamides. These carboxamides are known to act as inhibitors of IRAK4 (interleukin-1 receptor-associated kinase 4) activity. By inhibiting IRAK4, these carboxamides can potentially modulate the immune response and be utilized in the development of therapeutics for various inflammatory and autoimmune diseases.
Used in Chemical Synthesis:
In the chemical synthesis industry, t-Butyl (2-aMinocyclopentyl)carbaMate can be employed as a building block or intermediate for the synthesis of more complex molecules. Its unique structural features, including the carbamate group and the 2-aminocyclopentyl moiety, can be exploited to create a variety of novel compounds with diverse applications in different fields, such as materials science, agrochemistry, and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 1193388-07-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,3,3,8 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1193388-07:
(9*1)+(8*1)+(7*9)+(6*3)+(5*3)+(4*8)+(3*8)+(2*0)+(1*7)=176
176 % 10 = 6
So 1193388-07-6 is a valid CAS Registry Number.
1193388-07-6Relevant articles and documents
An improved chemoenzymatic synthesis of both enantiomers of trans-cyclopentane-1,2-diamine
Pena, Carmen,Gonzalez-Sabin, Javier,Rebolledo, Francisca,Gotor, Vicente
, p. 751 - 755 (2008)
An improved chemoenzymatic protocol for the synthesis of both enantiomers of trans-cyclopentane-1,2-diamine is described. The key part of the strategy relies on the synthesis and subsequent enzymatic resolution of its racemic precursor trans-N,N-diallylcy
CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF
-
Paragraph 0001338, (2017/07/06)
The present invention provides compounds, compositions thereof, and methods of using the same.
CARBOXAMIDE INHIBITORS OF IRAK4 ACTIVITY
-
Page/Page column 30, (2016/09/26)
The present invention relates to carboxamide inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.